Completed PHASE4 INTERVENTIONAL 2-arm NCT01254825

The Efficacy of Adductor-Canal-Block (ACB) in Patients After Knee Arthroscopy

Sponsor: Glostrup University Hospital, Copenhagen

Conditions Diagnostic Knee Artroscopy Meniscus Lesion Minor Knee Surgery Pain (Knee)

Interventions Adductor Canal Block, Placebo (saline) Adductor-Canal-Block, Ropivacain

Updated 6 times since 2017 Last updated: Sep 9, 2012 Started: Nov 30, 2010 Primary completion: Sep 30, 2011 Completion: Sep 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Diagnostic Knee Artroscopy and Meniscus Lesion and is currently completed. Glostrup University Hospital, Copenhagen leads this study, which shows 6 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Nov 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Glostrup University Hospital, Copenhagen

Data source: Glostrup University Hospital, Copenhagen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Glostrup Municipality, Denmark